Tradition, scientific research and data on the medicinal plant market in the Covid period will be discussed at the meeting to be held at SANA Restart, Friday 9 October from 2.30pm to 5.15pm at the Night Room, Service Center block D.
The times of Covid-19 will be remembered for the uninterrupted flow of information regarding the pandemic and possible remedies for the infection proved, some times, totally lacking in scientific evidence.
On the other hand, never before scientific research activity has been so intense, aimed at the development of a vaccine and at the study of active ingredients useful in preventing and better treating viral infection.
In the last case, more and more studies and researches concerning medicinal plants are in progress, due to their ancient use for nutritional and health purpose, also recognized as cultural heritage by UNESCO. The aim is a support in treatment of COVID diseases in the light of the most current scientific knowledge, multiple functionalities and traditional applications.
At the same time, worldwide, there has been an increase in the marketing of plant-derived health products, especially those intended to stimulate and strengthen natural defenses, based on vitamins and plant extracts, as confirmed by research data conducted by the American Botanical Council.
The meeting held at SANA Restart, Friday 9 October from 2.30pm to 5.15 pm at the Night Room, Service Center block D, want focus on scientific and market data on medicinal plants in a time of Covid-19.
14.30 – 15.00 The flavonoid quercetin for the well-being of the respiratory tract
ELISABETTA FRATTINI (Scientific comunication Indena S.p.A)
15.00 – 15.30 Colchicina, when history meets the present and illuminates the future!
MAURO LEPORE (Medical consultant)
15.30 – 16.00 Plantae Medicinales Mediterraneae: from the pan-Mediterranean tradition to
current scientific research
RITA PATRIZIA AQUINO (Full Professor Dept. of Pharmacy / DIFARMA Univ. of Salerno, UnescoChairSalerno)
16.00 – 16.30 Use of medicinal plants during the COVID-19 pandemic: an evaluation of some
of the most used ingredients
STEFAN GAFNER (PhD Chief Science Officer American Botanical Council)
16.30 – 17.15 QUESTION SESSION AND END OF WORK CHAIR: RENATO IGUERA (President ASSOERBE)